Accord Healthcare AB: vundne offentlige udbud

Ifølge tildelingsbekendtgørelser i TED har Accord Healthcare AB vundet 17 udbud hos danske ordregivere med en samlet oplyst værdi på 4.370.996.393 kr.. Den seneste tildeling er dateret 10. november 2026.

UdbudOrdregiverVindereVærdiDato
Amgros 2027 1.1492.aAmgros I/SAccord Healthcare AB, Recordati AB, Recordati AB807.275.236 kr.10. november 2026
Amgros 2027 1.1493.aAmgros I/SAstraZeneca A/S, AstraZeneca A/S, Institut Produits Synthése (IPSEN) AB, Orifarm A/S, Institut Produits Synthése (IPSEN) AB, Ferring Lægemidler A/S, Ferring Lægemidler A/S, Accord Healthcare AB196.584.887 kr.10. november 2026
Amgros 2027 2.1302.bAmgros I/SMacure Pharma ApS, Navamedic AB, Navamedic AB, Macure Pharma ApS, XGX Pharma ApS, Orifarm A/S, Macure Pharma ApS, Orifarm A/S, 2care4 ApS, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Navamedic AB, Hameln Pharma ApS, Navamedic AB, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Hameln Pharma ApS, Pfizer ApS, Orifarm A/S, MSD Danmark ApS, Hameln Pharma ApS, FrostPharma AB, Orifarm A/S, B. Braun Medical A/S, FrostPharma AB, Baxter A/S, Hameln Pharma ApS, Accord Healthcare AB, Hameln Pharma ApS, Accord Healthcare AB193.377.429 kr.29. oktober 2026
Amgros 2027 2.1302.bAmgros I/SMacure Pharma ApS, Navamedic AB, Navamedic AB, Macure Pharma ApS, XGX Pharma ApS, Orifarm A/S, Macure Pharma ApS, Orifarm A/S, 2care4 ApS, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Navamedic AB, Hameln Pharma ApS, Navamedic AB, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Hameln Pharma ApS, Pfizer ApS, Orifarm A/S, MSD Danmark ApS, Hameln Pharma ApS, FrostPharma AB, Orifarm A/S, B. Braun Medical A/S, FrostPharma AB, Baxter A/S, Hameln Pharma ApS, Accord Healthcare AB, Hameln Pharma ApS, Accord Healthcare AB193.377.429 kr.29. oktober 2026
Amgros 2027 2.690.bAmgros I/SSandoz A/S, Accord Healthcare AB, 2care4 ApS, Sandoz A/S, Accord Healthcare AB, Sandoz A/S, Sandoz A/S, Orifarm Generics A/S, STADA Nordic ApS, Sandoz A/S, Sandoz A/S, Viatris ApS, Sandoz A/S, Teva Denmark A/S, Haleon Denmark ApS, Orifarm Generics A/S, Zentiva Denmark ApS, Medical Valley Invest AB, Krka Sverige AB, Sandoz A/S, Orifarm Generics A/S, Medical Valley Invest AB, Orifarm Generics A/S, Sandoz A/S, Mundipharma A/S, 2care4 ApS, Teva Denmark A/S, Orifarm Generics A/S, Teva Denmark A/S, Mundipharma A/S, Orifarm Generics A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag102.193.408 kr.25. oktober 2026
Amgros 2027 2.690.bAmgros I/SSandoz A/S, Accord Healthcare AB, 2care4 ApS, Sandoz A/S, Accord Healthcare AB, Sandoz A/S, Sandoz A/S, Orifarm Generics A/S, STADA Nordic ApS, Sandoz A/S, Sandoz A/S, Viatris ApS, Sandoz A/S, Teva Denmark A/S, Haleon Denmark ApS, Orifarm Generics A/S, Zentiva Denmark ApS, Medical Valley Invest AB, Krka Sverige AB, Sandoz A/S, Orifarm Generics A/S, Medical Valley Invest AB, Orifarm Generics A/S, Sandoz A/S, Mundipharma A/S, 2care4 ApS, Teva Denmark A/S, Orifarm Generics A/S, Teva Denmark A/S, Mundipharma A/S, Orifarm Generics A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag102.193.408 kr.25. oktober 2026
Amgros 2027 2.703.bAmgros I/SSun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Zentiva Denmark ApS, Accord Healthcare AB, STADA Nordic ApS, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Pierre Fabre Pharma Norden AB, Norgine Danmark A/S, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Norgine Danmark A/S, Abacus Medicine A/S, Orifarm A/S, STADA Nordic ApS256.349.795 kr.13. oktober 2026
Amgros 2027 2.703.bAmgros I/SSun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Zentiva Denmark ApS, Accord Healthcare AB, STADA Nordic ApS, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Pierre Fabre Pharma Norden AB, Norgine Danmark A/S, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Norgine Danmark A/S, Abacus Medicine A/S, Orifarm A/S, STADA Nordic ApS256.349.795 kr.13. oktober 2026
Amgros 2027 2.703.bAmgros I/SSun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Zentiva Denmark ApS, Accord Healthcare AB, STADA Nordic ApS, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Pierre Fabre Pharma Norden AB, Norgine Danmark A/S, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Norgine Danmark A/S, Abacus Medicine A/S, Orifarm A/S, STADA Nordic ApS256.349.795 kr.13. oktober 2026
Amgros 2027 2.703.bAmgros I/SSun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Zentiva Denmark ApS, Accord Healthcare AB, STADA Nordic ApS, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Pierre Fabre Pharma Norden AB, Norgine Danmark A/S, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Norgine Danmark A/S, Abacus Medicine A/S, Orifarm A/S, STADA Nordic ApS256.349.795 kr.13. oktober 2026
Amgros 2027 2.703.bAmgros I/SSun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Zentiva Denmark ApS, Accord Healthcare AB, STADA Nordic ApS, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Pierre Fabre Pharma Norden AB, Norgine Danmark A/S, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Norgine Danmark A/S, Abacus Medicine A/S, Orifarm A/S, STADA Nordic ApS256.349.795 kr.13. oktober 2026
Amgros 2027 2.703.bAmgros I/SSun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Zentiva Denmark ApS, Accord Healthcare AB, STADA Nordic ApS, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Pierre Fabre Pharma Norden AB, Norgine Danmark A/S, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Norgine Danmark A/S, Abacus Medicine A/S, Orifarm A/S, STADA Nordic ApS256.349.795 kr.13. oktober 2026
Amgros 2027 2.703.bAmgros I/SSun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Zentiva Denmark ApS, Accord Healthcare AB, STADA Nordic ApS, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Pierre Fabre Pharma Norden AB, Norgine Danmark A/S, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Norgine Danmark A/S, Abacus Medicine A/S, Orifarm A/S, STADA Nordic ApS256.349.795 kr.13. oktober 2026
Amgros 2027 2.1200.aAmgros I/SMacure Pharma ApS, Macure Pharma ApS, Macure Pharma ApS, Orifarm A/S, Orifarm A/S, Aguettant Nordic ApS, Aguettant Nordic ApS, Zentiva Denmark ApS, Aguettant Nordic ApS, Øresund Pharma ApS, Macure Pharma ApS, Orifarm A/S, Macure Pharma ApS, GE Healthcare A/S, Accord Healthcare AB, Accord Healthcare AB, Abcur AB, Paranova Danmark A/S, 2care4 ApS73.487.895 kr.13. oktober 2026
Amgros 2027 2.1200.aAmgros I/SMacure Pharma ApS, Macure Pharma ApS, Macure Pharma ApS, Orifarm A/S, Orifarm A/S, Aguettant Nordic ApS, Aguettant Nordic ApS, Zentiva Denmark ApS, Aguettant Nordic ApS, Øresund Pharma ApS, Macure Pharma ApS, Orifarm A/S, Macure Pharma ApS, GE Healthcare A/S, Accord Healthcare AB, Accord Healthcare AB, Abcur AB, Paranova Danmark A/S, 2care4 ApS73.487.895 kr.13. oktober 2026
Amgros 2027 1.1052.bAmgros I/SBiocon Biologics Ireland Limited, Orion Pharma A/S, Pfizer ApS, Samsung Bioepis NL B.V., Accord Healthcare AB, Roche Pharmaceuticals A/S, Orifarm A/S, Abacus Medicine A/S, 2care4 ApS704.000.000 kr.21. september 2026
Amgros 2026 1.630.bAmgros I/SZentiva Denmark ApS, Medical Valley Invest AB, Zentiva Denmark ApS, Viatris ApS, Accord Healthcare AB, Merz Therapeutics Nordics AB130.570.241 kr.10. september 2026

Datakilde: TED © Den Europæiske Union. Tildelingsbekendtgørelser fra danske ordregivere.

Vinderbadge til din hjemmeside

Repræsenterer du Accord Healthcare AB? Kopiér koden og indsæt den på jeres hjemmeside. Badget linker til denne side.

Forhåndsvisning:

🏆 Accord Healthcare AB har vundet offentlige udbud – se udbuddene på EU-udbud.dk